Document is current
Any future updates will be listed below
-
Authors
Anand, Kartik
Patel, Tejal
Niravath, Polly
Rodriguez, Angel
Darcourt, Jorge
Belcheva, Anna
Boone, Toniva
Ensor, Joe
Chang, Jenny
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01931163 at ClinicalTrials.govDocuments that mention this clinical trial
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy
https://doi.org/10.1038/s41598-020-80081-y
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Received: 14 July 2020
Accepted: 11 December 2020
First Online: 8 January 2021
Competing interests
: The authors declare no competing interests.
